ZA

Michael Christian Norris

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Christian Norris. Retrieved from https://idiyas.com/inventor/michael-christian-norris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Michael Christian Norris: Innovator in Pharmaceutical Compositions

Introduction

Michael Christian Norris is a notable inventor based in South Africa. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that combine COX-2 inhibitors and opiates. His work aims to enhance pain relief methods, especially in conditions associated with inflammation.

Latest Patents

Michael Christian Norris holds a patent for a pharmaceutical composition that comprises a combination of a selective or specific COX-2 inhibitor and an opiate. This composition is designed to provide symptomatic relief or treatment of pain in various conditions, including osteoarthritis and rheumatoid arthritis. The patent details a combination of meloxicam and codeine as active ingredients, along with a pharmaceutically acceptable carrier. This innovative approach addresses pain management effectively, particularly in inflammatory states.

Career Highlights

Michael Christian Norris is associated with Adcock Ingram Limited, a prominent pharmaceutical company in South Africa. His role at the company allows him to contribute to the development of effective pharmaceutical solutions that cater to the needs of patients suffering from pain and inflammation.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Michael Christian Norris is a dedicated inventor whose work in pharmaceutical compositions showcases his commitment to improving pain management. His innovative approach has the potential to significantly impact the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…